kw.\*:("dyslipidaemia")
Results 1 to 25 of 178
Selection :
Impact of Low- or High-Flux Haemodialysis and Online Haemodiafiltration on Inflammatory Markers and Lipid Profile in Chronic Haemodialysis PatientsAKOGLU, Hadim; DEDE, Fatih; PISKINPASA, Serhan et al.Blood purification. 2013, Vol 35, Num 4, pp 258-264, issn 0253-5068, 7 p.Article
PitavastatinMUKHTAR, R. Y. A; REID, J; RECKLESS, J. P. D et al.International journal of clinical practice (Esher). 2005, Vol 59, Num 2, pp 239-252, issn 1368-5031, 14 p.Article
Obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal womenGEISTHÖVEL, F; OLBRICH, M; FRORATH, B et al.Human reproduction (Oxford. Print). 1994, Vol 9, Num 4, pp 610-616, issn 0268-1161Article
Dietary lipid modification for mild and severe dyslipidaemias : Transforming the nutrition landscape in AfricaMARAIS, A. David.Proceedings of the Nutrition Society. 2013, Vol 72, Num 3, pp 337-341, issn 0029-6651, 5 p.Conference Paper
Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese womenWEI, W; LI, Y; CHEN, F et al.Journal of human hypertension. 2011, Vol 25, Num 6, pp 364-371, issn 0950-9240, 8 p.Article
Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing processYOKOZAWA, Takako; HYUN YOUNG KIM; HYUN JU KIM et al.British journal of nutrition. 2007, Vol 97, Num 6, pp 1187-1195, issn 0007-1145, 9 p.Article
Nutritional Status and Lipid Profile of Young Children in BrazilALVES PEREIRA, Joilane; CARVALHO RONDO, Patricia Helen; OLIVEIRA LEMOS, Jesuana et al.Journal of tropical pediatrics (1980). 2013, Vol 59, Num 1, pp 54-58, issn 0142-6338, 5 p.Article
Adipose tissue in obesity and obstructive sleep apnoeaBONSIGNORE, M. R; MCNICHOLAS, W. T; MONTSERRAT, J. M et al.The European respiratory journal. 2012, Vol 39, Num 3, pp 746-767, issn 0903-1936, 22 p.Article
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsKRISHNA, Rajesh; STYPINSKI, Daria; WAGNER, John A et al.British journal of clinical pharmacology. 2012, Vol 74, Num 1, pp 116-124, issn 0306-5251, 9 p.Article
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesityCHRISTOPOULOU, F. D; KIORTSIS, D. N.Journal of clinical pharmacy and therapeutics (Print). 2011, Vol 36, Num 1, pp 10-18, issn 0269-4727, 9 p.Article
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled studyLOCATELLI, Francesco; DIMKOVIC, Nada; PONTORIERO, Giuseppe et al.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 2, pp 574-581, issn 0931-0509, 8 p.Article
The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective studyMICHIE, C. O; SAKALA, M; RIVANS, I et al.British journal of cancer. 2010, Vol 103, Num 5, pp 617-621, issn 0007-0920, 5 p.Article
Combination therapy in the management of mixed dyslipidaemiaCANNON, C. P.Journal of internal medicine. 2008, Vol 263, Num 4, pp 353-365, issn 0954-6820, 13 p.Article
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia : final results of the SLOAT trialSORIANO, Vincent; GARCIA-GASCO, Pilar; BARREIRO, Pablo et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 1, pp 200-205, issn 0305-7453, 6 p.Article
Prescreening tools for diabetes and obesity- associated dyslipidaemia : comparing BMI, waist and waist hip ratio. The D.E.s.I.R. StudyBAIKAU, B; SAPINHO, D; PETRELLA, A et al.European journal of clinical nutrition. 2006, Vol 60, Num 3, pp 295-304, issn 0954-3007, 10 p.Article
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovirLLIBRE, Josep M; DOMINGO, Pere; PALACIOS, Rosario et al.AIDS (London). 2006, Vol 20, Num 10, pp 1407-1414, issn 0269-9370, 8 p.Article
Erfolge in der Prävention der koronaren Herzkrankheit durch Behandlung von Fettstoffwechselstörungen = Success in the prevention of coronary artery disease through treatment of lipid disordersWINDLER, E.Intensivmedizin + Notfallmedizin. 1994, Vol 31, Num 5, pp 205-212, issn 0175-3851Article
Ineffectiveness of lipid-lowering therapy in primary careVAN GANSE, E; SOUCHET, T; LAFOREST, L et al.British journal of clinical pharmacology. 2005, Vol 59, Num 4, pp 456-463, issn 0306-5251, 8 p.Article
Blood pressure control status and effects of pravastatin on cardiovascular events occurrence in patients with dyslipidaemiaKUSHIRO, T; MIZUNO, K; NAKAYA, N et al.Journal of human hypertension. 2012, Vol 26, Num 6, pp 388-395, issn 0950-9240, 8 p.Article
Pleiotropic effects of pitavastatinDAVIGNON, Jean.British journal of clinical pharmacology. 2012, Vol 73, Num 4, pp 518-535, issn 0306-5251, 18 p.Article
Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemiaBROUWERS, Martijn C. G. J; VAN GREEVENBROEK, Marleen M. J; TROUTT, Jason S et al.Clinical science (1979). 2011, Vol 121, Num 9-10, pp 397-403, issn 0143-5221, 7 p.Article
NIACIN, AN OLD DRUG WITH NEW PERSPECTIVES FOR THE MANAGEMENT OF DYSLIPIDAEMIABENHALIMA, K; MULS, E.Acta clinica belgica (Ed. multilingue). 2010, Vol 65, Num 1, pp 23-28, issn 0001-5512, 6 p.Article
Lichen planus and dyslipidaemia: a case-control studyDREIHER, J; SHAPIRO, J; COHEN, A. D et al.British journal of dermatology (1951). 2009, Vol 161, Num 3, pp 626-629, issn 0007-0963, 4 p.Article
Thiazolidinediones : effects on the development and progression of type 2 diabetes and associated vascular complicationsKRENTZ, Andrew.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 2, pp 112-126, issn 1520-7552, 15 p.Article
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders : ObesityHEAL, David J; GOSDEN, Jane; SMITH, Sharon L et al.British journal of clinical pharmacology. 2009, Vol 68, Num 6, issn 0306-5251, 861-874, 968 [15 p.]Article